Bath ASU’s full-time research and development laboratory does valuable work to improve the safety and stability of patient-bound products.
The Bath ASU research team makes some of its stability research available to hospitals. Some information is shared subject to a licence agreement. Stability information is currently available for:
- Herzuma (Trastuzumab) — available on request
- Remsima (Infliximab)
- Rixathon (Rituximab) — available on request
- Truxima (Rituximab) — available on request